Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections.

Sheyda SofizadehHenrik ImbergArndís F ÓlafsdóttirMagnus EkelundSofia DahlqvistIrl HirschKarin FilipssonBo AhrénStefan SjöbergJaako TuomilehtoMarcus Lind

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)

Novo Nordisk funded this study. The Diabetes Research Unit, NU-Hospital Group funded the journal's Rapid Service Fee.

Keyphrases

type diabetes
glycemic control
healthcare
cardiovascular disease
insulin resistance
mental health
adverse drug
platelet rich plasma